Melita Jung

Melita Jung

Corporate Officer/Principal en TERNS PHARMACEUTICALS, INC. .

Fortuna: - $ al 30/04/2024

47 años
Health Technology
Consumer Services
Commercial Services

Perfil

Melita Sun Jung is currently the Chief Business Officer at Terns Pharmaceuticals, Inc. She previously held positions as the Senior Director-Corporate Development at Adamas Pharmaceuticals LLC from 2014 to 2017, the Head-Business Development at Sangamo Therapeutics, Inc. from 2017 to 2021, and the Vice President-Business Development at Ascendancy Healthcare, Inc. from 2012 to 2014.
She also served as the Chief Business Officer at Structure Therapeutics, Inc. Ms. Jung completed her undergraduate degree at the University of California, Berkeley.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
07/02/2023 0 ( -.--% ) - $ 30/04/2024

Cargos activos de Melita Jung

EmpresasCargoInicio
TERNS PHARMACEUTICALS, INC. Corporate Officer/Principal 22/04/2024
Todos los cargos activos de Melita Jung

Antiguos cargos conocidos de Melita Jung.

EmpresasCargoFin
SANGAMO THERAPEUTICS, INC. Corporate Officer/Principal 01/01/2021
ADAMAS PHARMACEUTICALS, INC. Corporate Officer/Principal 01/06/2017
Corporate Officer/Principal 01/05/2014
STRUCTURE THERAPEUTICS INC. Corporate Officer/Principal -
Ver el detalle de la experiencia de Melita Jung.

Formación de Melita Jung.

University of California, Berkeley Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Melita Jung.

Relaciones

62

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas3
SANGAMO THERAPEUTICS, INC.

Health Technology

STRUCTURE THERAPEUTICS INC.

Commercial Services

TERNS PHARMACEUTICALS, INC.

Health Technology

Empresas privadas2

Health Technology

Health Technology

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA